Pharmaceutical And Hospital Robotics Market Report
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
In 2018, the global pharmaceutical market has just crossed US$ 1 Trillion mark. The industry is growing leaps and bounds, but the manufacturers are still looking for options which can bring down the cost of manufacturing and increase profit margins.
Currently the industry produces billions of medicines each month which undergo a series of inspection, before being packaged and distributed. It adds cost every time a batch of medicine undergoes quality check, capping, labelling and bottle orientation. The introduction of pharmaceutical robots has been adopted by a lot of companies and it is making an overall difference in the manufacturing cost. The report explores the market from demand and supply perspective and segments market into immediate opportunity, near-term and long-term opportunity.
Recently UK based Oxford Biomedica has announced its plan to introduce digital and robotic capabilities in its facility with an estimated budget of $5.1 Million in early 2019. Although it may appear expensive in short term, the benefits are manifold and go a long way to help the manufacturers reduce the manufacturing cost, reduce the waste and increase the production capacity.
Robot types include articulated, Cartesian (i.e. gantry), parallel (delta), and selective compliance assembly robot arm (SCARA). Common applications include “pick and place operations that often use SCARA Robots. In recent years there has been an emerging demand for delta-type of robots for high speed picking and packaging. One of the Tier 1 pharmaceutical companies Merck is using Fanuc Robots from UK, which is set up on bottling line to place dispenser caps onto bottled allergy medications. With Fanuc’s new technology, the pharmaceutical company can use ten variants of the bottle simultaneously through robot controller. The same process would have doubled the effort and time if processed manually.
USA is a major market for pharmaceutical robots and 34-38% of the current medicine manufacturing and processing is conducted using robots. This market is expected to grow steadily at 11-12% CAGR from 2020 to 2025. US based ESS Technologies have adopted robotics for handling plastic syringes and glass pre-filled syringes in pre-process, buffering, inspection and end of line packaging. This has brought down the manufacturing cost due to reduced time for QC (no human touch), higher quality, faster packaging and more output in a sterile environment. The company also uses robotic technology for slow speed applications such as vial-filling, or automatic inspection.
Fanuc Robotics UK is one of the prominent companies in Western Europe which focuses on the pharmaceutical robotic technology. Another prominent example is Invetech, contract manufacturing company, which has partnered with Argos Therapeutics to develop automated manufacturing technology based on Arcelis technology. Robotics has found a wide range of application areas from drug delivery, to manufacturing, packaging and even personalized medicines in both pharmaceutical industry and life sciences market.
On the other hand, hospital robotics have a unique application which not only assists in surgery, but also in hospital services, data mining and capture, pharmacy, nursing robots, and several other departments. This has brought down the cost of operations and has increased precision in areas such as surgery and medicine distribution, leading to less medical errors and higher patient compliance.
USA is one of the major market for surgical robots. The adoption of hospital robots in surgery has reduced the post-operative pain, shortened hospital stay, added precision to the surgeon, and ensured early patient mobility and faster recovery. Surgeons who have been using surgical robots agree that it gives them 7 degrees of freedom and 90 degrees of articulation which is as good as having miniaturized hands inside the subject’s body. Incorporation of navigation technology in surgical robots have further enhanced the outcome. For e.g., GPS 3D guidance system has improved accuracy and optimizes patient care by integrating robotics with navigation.
The report studies the demand for “Da Vinci” surgical robots apart from Surgical robots like Versius to help the reader get a sense of the future demand, hurdles and opportunities in some of the major markets for hospital robots. Hospital Robotics is an eco-system in itself and not limited to just surgical robots. The report tries to conduct a comparative analysis of all the departments where hospital can use robotic technology in future.
For more queries, please write to [email protected]